BTK and infection: According to our current knowledge; use of Bruton Tyrosine kinase (BTK) inhibitors can impair some functions of the innate immunity and increases the susceptibility to infections or impaired humoral immunity in patients.[13] Two pilot studies those were conducted on B cell malignancies revealed that BTK inhibition may have protective effects against SARS-CoV2 virulence.[14, 15]